Eitan Medical UK Limited Filleted Accounts Cover
Eitan Medical UK Limited
Audited accounts
Company No. 12738832
Information for Filing with The Registrar
31 December 2023
Eitan Medical UK Limited Directors Report Registrar
The Directors present their report and the accounts for the year ended 31 December 2023.
Principal activities
The principal activity of the company during the year under review was selling and marketing of medical supplies.
Directors
The Directors who served at any time during the year were as follows:
B. Dvir
(Resigned 13 July 2023)
G.Y. Hadar
I. Shany
(Resigned 1 January 2024)
Statement of directors' responsibilities
The Directors are responsible for preparing the Directors' report and the accounts in accordance with applicable law and regulations.
Company law requires the directors to prepare accounts for each financial year. Under that law the directors have elected to prepare the accounts in accordance with united Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the accounts unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these accounts, the directors are required to:
*
select suitable accounting policies and then apply them consistently;
*
make judgments and estimates that are reasonable and prudent;
*
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Statement of disclosure of information to auditor
So far as the directors are aware, there is no relevant audit information of which the company's auditors are unaware and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant information and to establish that the company's auditors are aware of that information.
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
G.Y. Hadar
Director
19 September 2024
Eitan Medical UK Limited Balance Sheet Registrar
at
31 December 2023
Company No.
12738832
Notes
2023
2022
£
£
Fixed assets
Tangible assets
4
1751,872
1751,872
Current assets
Stocks
5
744,240880,087
Debtors
6
447,341483,027
Cash at bank and in hand
311,857135,124
1,503,4381,498,238
Creditors: Amount falling due within one year
7
(1,923,671)
(2,014,734)
Net current liabilities
(420,233)
(516,496)
Total assets less current liabilities
(420,058)
(514,624)
Net liabilities
(420,058)
(514,624)
Capital and reserves
Called up share capital
11
Profit and loss account
8
(420,059)
(514,625)
Total equity
(420,058)
(514,624)
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 19 September 2024
And signed on its behalf by:
G.Y. Hadar
19 September 2024
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 19 September 2024
And signed on its behalf by:
G.Y. Hadar
Director
19 September 2024
Eitan Medical UK Limited Notes to the Accounts Registrar
for the year ended 31 December 2023
1
General information
Its registered number is: 12738832
Its registered office is:
201 Haverstock Hill
Second Floor
London
England
NW3 4QG
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2
Accounting policies
Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:
• the Company has transferred to the buyer the significant risks and rewards of ownership of the
goods;
• the Company retains neither continuing managerial involvement to the degree usually associated
with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the economic benefits associated with the transaction will flow to the Company;
and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
Furniture, fittings and equipment
33% Straight line
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors including expectations of future events that are believed to be reasonable under the circumstances.
Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs.
Taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at
the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or
substantially enacted at the reporting date.
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.

When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of inventories recognised as an expense in the period in which the reversal occurs.

Work in progress is reflected in the accounts on a contract by contract basis by recording revenue and related costs as contract activity progresses.
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Foreign currencies
The functional and presentational currency of the company is Sterling. The accounts are rounded to the nearest pound.
Transactions in currencies, other than the functional currency of the Company, are recorded at the rate of exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. all differences are taken to the profit and loss account. Non-monetary items that are measured at historic cost in a foreign currency are not retranslated.
Operating leases: as lessee
Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.
Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on
notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more
than three months from the date of acquisition and that are readily convertible to known amounts of
cash with insignificant risk of change in value.
Defined benefit pensions
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations.

The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
Going concern
These financial statements have been prepared on a going concern basis. The director, having considered the financial position of the company for a period of at least twelve months from the date of signing these financial statements, has no reason to believe that a material uncertainty exists that may cast doubt about the ability of the company to continue as a going concern. Accordingly the director has a reasonable expectation that the company will continue in operational existence and therefore he continues to adopt the going concern basis of accounting to prepare the financial statements.
3
Employees
2023
2022
Number
Number
The average monthly number of employees (including directors) during the year was:
55
4
Tangible fixed assets
Fixtures, fittings and equipment
Total
£
£
Cost or revaluation
At 1 January 2023
5,9065,906
At 31 December 2023
5,9065,906
Depreciation
At 1 January 2023
4,0344,034
Charge for the year
1,6971,697
At 31 December 2023
5,7315,731
Net book values
At 31 December 2023
175175
At 31 December 2022
1,872
1,872
5
Stocks
2023
2022
£
£
Finished goods
744,240880,087
744,240880,087
6
Debtors
2023
2022
£
£
Trade debtors
434,152480,482
Other debtors
2,3781,118
Prepayments and accrued income
10,8111,427
447,341483,027
7
Creditors:
amounts falling due within one year
2023
2022
£
£
Trade creditors
23,06713,657
Taxes and social security
105,343
79,384
Other creditors
1,595,3771,873,009
Accruals and deferred income
199,88448,684
1,923,6712,014,734
8
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
9
Guarantees and commitments
2023
2022
£
£
Total of guarantees and commitments
4,3702,795
10
Related party disclosures
Transactions with related parties
The company has taken advantage of the exemption available according to FRS 102 1A "Related party
disclosure" not to disclose transactions entered into between two or more members of a group that are
wholly owned.
Parent Company
The name of the parent of the smallest group for which consolidated financial statements are drawn up of which this entity is a member:
Eitan Medical Ltd
The parent's registered office address is:
29 Yad Haruzim St.
P.O. Box 8639
Netanya
4250529 Israel
11
Audit of the accounts
The directors have required the company to obtain an audit.
Unqualified
The auditors were: Gordon Levy Limited
The senior statutory auditor was: Gordon Levy, BA, FCA
Eitan Medical UK Limited1273883231 December 202301 January 2023false19 September 2024BTCSoftware AP Solution 2024 11.1.0211.1.02For the year ended 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.true127388322023-01-012023-12-31127388322023-12-31127388322022-12-3112738832core:WithinOneYear2023-12-3112738832core:WithinOneYear2022-12-3112738832core:ShareCapital2023-12-3112738832core:ShareCapital2022-12-3112738832core:RetainedEarningsAccumulatedLosses2023-12-3112738832core:RetainedEarningsAccumulatedLosses2022-12-3112738832bus:RegisteredOffice2023-01-012023-12-3112738832core:FurnitureFittingsToolsEquipment2023-01-012023-12-31127388322022-01-012022-12-3112738832core:FurnitureFittingsToolsEquipment2023-01-01127388322023-01-0112738832core:FurnitureFittingsToolsEquipment2023-12-3112738832core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3112738832bus:SmallEntities2023-01-012023-12-3112738832bus:FullAccounts2023-01-012023-12-3112738832bus:AuditExempt-NoAccountantsReport2023-01-012023-12-3112738832bus:Director32023-01-012023-12-3112738832bus:PrivateLimitedCompanyLtd2023-01-012023-12-31iso4217:GBPxbrli:pure